When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy?
NCT ID: NCT02742636
Last Updated: 2017-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
162 participants
INTERVENTIONAL
2016-05-31
2017-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study design: Randomized Controlled trial, non-inferiority study.
Study population: Women older than 18 years old, who are a laparoscopic hysterectomy for benign indication or low-grade malignancy.
Intervention:
* Group A (treatment group): the patients in this group will have their catheter directly removed in the OR after LH.
* Group B (control group): the patients in the control group will have their catheter removed according to the regular protocol of the hospital (at least 6 hours in place).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Randomized Control Trial Comparing Immediate and 24-hours Delayed Catheter Removal Following Hysterectomy
NCT01182714
Postoperative Urinary Retention and Urinary Track Infection (UTI) After Laparoscopic Assisted Vaginal Hysterectomy (LAVH) for Benign Disease
NCT00564135
The Effect of Clamping the Indwelling Urethral Catheter Before Removal From Patients After Type III Radical Hysterectomy
NCT02083614
Removal of Urinary Catheter After Radical Surgery
NCT03570593
Self-discontinuation of Urinary Catheters in a Rural Population
NCT07041151
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (treatment group)
The patients in this group will have their catheter directly removed in the OR after LH.
Foley catheter
The aim of this study is to evaluate if direct removal of the urine catheter after an LH (total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter removal after surgery.
Group B (control group)
The patients in the control group will have their catheter removed according to the regular protocol of the hospital (at least 6 hours in place).
Foley catheter
The aim of this study is to evaluate if direct removal of the urine catheter after an LH (total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter removal after surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Foley catheter
The aim of this study is to evaluate if direct removal of the urine catheter after an LH (total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter removal after surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for LH for benign indication or low-grade malignancy (with or without salpingo-oophorectomy)
Exclusion Criteria
* Preoperative known urinary voiding problems (incontinence)
* Preoperative known urinary tract infection
* Patients suffering from diseases potentially associated with inability to void (e.g. MS)
* A Gravid or postpartum hysterectomy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bronovo Hospital
OTHER
Haga Hospital
OTHER
Alrijne Hospital
OTHER
Reinier de Graaf Groep
OTHER
Groene Hart Ziekenhuis
OTHER
Medical Center Haaglanden
OTHER
Leiden University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
FWJansen
Prof. Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Leiden University Medical Center
Leiden, North Holland, Netherlands
Reinier de Graaf Groep
Delft, , Netherlands
Groene Hart Ziekenhuis
Gouda, , Netherlands
Alrijne Hospital
Leiden, , Netherlands
Bronovo Hospital
The Hague, , Netherlands
Haga Hospital
The Hague, , Netherlands
Medisch Centrum Haaglanden
The Hague, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ellahi A, Stewart F, Kidd EA, Griffiths R, Fernandez R, Omar MI. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev. 2021 Jun 29;6(6):CD004011. doi: 10.1002/14651858.CD004011.pub4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P15.382
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.